# FDA Inspection 1230105 - Novartis Pharmaceuticals Corporation - June 27, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/b5b9853a-4053-4f24-8ef7-e9061d8ecd8a/
Source feed: FDA_Inspections

> FDA Inspection 1230105 for Novartis Pharmaceuticals Corporation on June 27, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230105
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2024-06-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276202 - 2025-06-25](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/3303ef9b-e9df-40c1-ae82-b9aa34bb6c57/)
- [FDA Inspection 1276202 - 2025-06-25](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/d76eeb82-f498-4fa6-9c50-25c0625a0d59/)
- [FDA Inspection 1263198 - 2025-03-03](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/ad5f75b3-032d-4614-ab72-4090e385dec1/)
- [FDA Inspection 1263198 - 2025-03-03](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/065307bf-8ec2-419d-a241-59ae20580926/)
- [FDA Inspection 1257911 - 2024-11-19](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/74d1a62a-d9e2-4b53-ba1e-0184aaea8099/)

Company: https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/aa4c85c1-794a-407a-8eb3-8802c196795b

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c